You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Cardiovascular Diseases and Risk of Hip Fracture
Ulf Sennerby; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Hans Garmo; Anders Ahlbom; Nancy L. Pedersen; Karl Michaëlsson
JAMA 2009; 302: 1666-1673.
[Abstract][Full text][PDF]
The World in Medicine Predicting Joint Replacement
Preliminary Communications Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
Marietta Charakida; Christian Besler; Joana R. Batuca; Shirish Sangle; Susanna Marques; Miguel Sousa; Guosu Wang; Dimitris Tousoulis; Jose Delgado Alves; Stavros P. Loukogeorgakis; Charles Mackworth-Young; David D’Cruz; Thomas Luscher; Ulf Landmesser; John E. Deanfield
JAMA 2009; 302: 1210-1217.
[Abstract][Full text][PDF]
Original Contributions Trends in Hip Fracture Rates in Canada
William D. Leslie; Siobhan O’Donnell; Sonia Jean; Claudia Lagacé; Peter Walsh; Christina Bancej; Suzanne Morin; David A. Hanley; Alexandra Papaioannou; for the Osteoporosis Surveillance Expert Working Group
JAMA 2009; 302: 883-889.
[Abstract][Full text][PDF]
Book and Media Reviews Kelley’s Textbook of Rheumatology
Reductase Inhibitors and Risk of Hip Fracture—Reply